A Phase II, Multicenter, Randomized, Double Blind, Vehicle Controlled Study Evaluating the Efficacy and Tolerability of AS101 15% Gel for External Genital Warts
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs AS 101 (Primary)
- Indications Genital warts
- Focus Proof of concept; Therapeutic Use
- Sponsors BioMAS
- 21 Jul 2017 According to a Cassiopea media release, 73% of the total enrollment has been completed in the trial.
- 31 Oct 2016 Planned End Date changed from 1 Jan 2016 to 1 May 2017.
- 31 Oct 2016 Planned primary completion date changed from 1 Jan 2016 to 1 May 2017.